Fero Industries introduces OTC type-2 diabetes drug in Mexico
The dug has been approved as OTC by the Mexican regularity authority and is distributed under an exclusive agreement with Merck S.A. de C.V. in Mexico. The preclinical

The dug has been approved as OTC by the Mexican regularity authority and is distributed under an exclusive agreement with Merck S.A. de C.V. in Mexico. The preclinical

Akrimax Pharma claims that NitroMist belongs to a group of drugs called nitrates. Nitroglycerin dilates (widens) blood vessels, making it easier for blood to flow through them and

Under the agreement, the companies will work on process development and manufacturing for MorphoSys’ proprietary MOR208 program and other drug candidates. MOR208 is a monoclonal anti-CD19 antibody is

With this move, Novartis has joined Pfizer, GlaxoSmithKline and AstraZeneca, who have recently closed their R&D units in the UK. The Horsham site has almost 950 full-time equivalent

RGN-352 is an injectable formulation to treat cardiovascular and central nervous system diseases, as well as other medical indications. RegeneRx said that the suspension of the trial is

ACH-1625 is Achillion‘s phase 2 protease inhibitor to treat hepatitis C virus (HCV) infection. The new patent, entitled ‘4-amino-4-oxobutanoyl peptides as inhibitors of viral replication,’ provides a patent

FivePrime, a clinical-stage, privately-held, biotechnology company discovering and developing innovative protein and antibody therapeutics, will retain minority co-promotion rights in the US and full development and commercialization rights

PharmaPros claims that Dataflow Manager offers the ability to manage clinical trials using the most accurate and up-to-date information available, enabling trial managers to make rapid and better-informed

Pramlintide acetate is a synthetic analog of the natural hormone amylin, a neurohormone secreted by the pancreas that is known to play a role in the regulation of

The suit alleges Alnylam exploited its confidential relationship as a collaborator with Tekmira to engage in inappropriate and harmful conduct concerning Tekmira’s proprietary lipid nanoparticle (LNP) siRNA delivery